Breast cancer after prophylactic mastectomy for Lobular Carcinoma-In-Situ (LCIS) - an unusual case

Bilateral risk reducing mastectomy results in the greatest breast cancer risk reduction but is an irreversible intervention. Total mastectomy can never remove all breast tissue and there is always a small risk of breast cancer. Regular follow up and surveillance is beneficial. We present the case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gurjar, N, Basit, A, Thomson, C, Kirby, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JSCR Publishing Ltd 2012
Materias:
Breast Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649648/
https://www.ncbi.nlm.nih.gov/pubmed/24960742
http://dx.doi.org/10.1093/jscr/2012.10.2
_version_ 1782269009353244672
author Gurjar, N
Basit, A
Thomson, C
Kirby, R
author_facet Gurjar, N
Basit, A
Thomson, C
Kirby, R
author_sort Gurjar, N
collection PubMed
description Bilateral risk reducing mastectomy results in the greatest breast cancer risk reduction but is an irreversible intervention. Total mastectomy can never remove all breast tissue and there is always a small risk of breast cancer. Regular follow up and surveillance is beneficial. We present the case of a 47-year-old woman who presented with axillary lymph node metastatic breast cancer after risk reducing mastectomy in which only Lobular Carcinoma-in-Situ (LCIS) was present on histopathology.
format Online
Article
Text
id pubmed-3649648
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher JSCR Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-36496482013-05-20 Breast cancer after prophylactic mastectomy for Lobular Carcinoma-In-Situ (LCIS) - an unusual case Gurjar, N Basit, A Thomson, C Kirby, R J Surg Case Rep Breast Surgery Bilateral risk reducing mastectomy results in the greatest breast cancer risk reduction but is an irreversible intervention. Total mastectomy can never remove all breast tissue and there is always a small risk of breast cancer. Regular follow up and surveillance is beneficial. We present the case of a 47-year-old woman who presented with axillary lymph node metastatic breast cancer after risk reducing mastectomy in which only Lobular Carcinoma-in-Situ (LCIS) was present on histopathology. JSCR Publishing Ltd 2012-10-01 /pmc/articles/PMC3649648/ /pubmed/24960742 http://dx.doi.org/10.1093/jscr/2012.10.2 Text en © JSCR
spellingShingle Breast Surgery
Gurjar, N
Basit, A
Thomson, C
Kirby, R
Breast cancer after prophylactic mastectomy for Lobular Carcinoma-In-Situ (LCIS) - an unusual case
title Breast cancer after prophylactic mastectomy for Lobular Carcinoma-In-Situ (LCIS) - an unusual case
title_full Breast cancer after prophylactic mastectomy for Lobular Carcinoma-In-Situ (LCIS) - an unusual case
title_fullStr Breast cancer after prophylactic mastectomy for Lobular Carcinoma-In-Situ (LCIS) - an unusual case
title_full_unstemmed Breast cancer after prophylactic mastectomy for Lobular Carcinoma-In-Situ (LCIS) - an unusual case
title_short Breast cancer after prophylactic mastectomy for Lobular Carcinoma-In-Situ (LCIS) - an unusual case
title_sort breast cancer after prophylactic mastectomy for lobular carcinoma-in-situ (lcis) - an unusual case
topic Breast Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649648/
https://www.ncbi.nlm.nih.gov/pubmed/24960742
http://dx.doi.org/10.1093/jscr/2012.10.2
work_keys_str_mv AT gurjarn breastcancerafterprophylacticmastectomyforlobularcarcinomainsitulcisanunusualcase
AT basita breastcancerafterprophylacticmastectomyforlobularcarcinomainsitulcisanunusualcase
AT thomsonc breastcancerafterprophylacticmastectomyforlobularcarcinomainsitulcisanunusualcase
AT kirbyr breastcancerafterprophylacticmastectomyforlobularcarcinomainsitulcisanunusualcase

Ejemplares similares